BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11099696)

  • 1. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.
    Raman P; Judd RL
    Eur J Pharmacol; 2000 Dec; 409(1):19-29. PubMed ID: 11099696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes.
    Raman P; Foster SE; Stokes MC; Strenge JK; Judd RL
    Life Sci; 1998; 62(8):PL89-94. PubMed ID: 9489515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.
    Fujiwara T; Okuno A; Yoshioka S; Horikoshi H
    Metabolism; 1995 Apr; 44(4):486-90. PubMed ID: 7723671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
    Fulgencio JP; Kohl C; Girard J; Pégorier JP
    Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute troglitazone action in isolated perfused rat liver.
    Preininger K; Stingl H; Englisch R; Fürnsinn C; Graf J; Waldhäusl W; Roden M
    Br J Pharmacol; 1999 Jan; 126(1):372-8. PubMed ID: 10051158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver.
    Adams MD; Raman P; Judd RL
    Biochem Pharmacol; 1998 Jun; 55(11):1915-20. PubMed ID: 9714310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.
    Davies GF; Khandelwal RL; Roesler WJ
    Biochim Biophys Acta; 1999 Aug; 1451(1):122-31. PubMed ID: 10446394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
    Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
    Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
    Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes.
    Murano K; Inoue Y; Emoto M; Kaku K; Kaneko T
    Eur J Pharmacol; 1994 Mar; 254(3):257-62. PubMed ID: 8013560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
    Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
    Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on the action of CS-045, a new antidiabetic agent.
    Ciaraldi TP; Gilmore A; Olefsky JM; Goldberg M; Heidenreich KA
    Metabolism; 1990 Oct; 39(10):1056-62. PubMed ID: 2120548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
    Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
    Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone stimulates acetyl-CoA carboxylase activity through a post-translational mechanism.
    Thampy GK; Haas MJ; Mooradian AD
    Life Sci; 2000 Dec; 68(6):699-708. PubMed ID: 11205884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways.
    Lenhard JM; Kliewer SA; Paulik MA; Plunket KD; Lehmann JM; Weiel JE
    Biochem Pharmacol; 1997 Oct; 54(7):801-8. PubMed ID: 9353134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle.
    Fürnsinn C; Brunmair B; Neschen S; Roden M; Waldhäusl W
    J Pharmacol Exp Ther; 2000 May; 293(2):487-93. PubMed ID: 10773019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.